A few days ago a transapical aortic valve implantation (TAVI) was performed with absolute success -and for the first time in Greece- using the SYMETIS transcatheter aortic valve at Mediterraneo Hospital. Minimal access technique with a small surgical incision was used. The operation was performed on an octogenarian male who had previously been operated on with Coronary Artery Bypass Grafting by the same team 13 years ago.
Decision to proceed with the transapical approach was dictated by the multiple comorbidities (pulmonary disease, peripheral vascular disease), old age, previous successful operation and the lack of peripheral vascular access (which would enable the more conservative percutaneous transcatheter implantation).
The successful operation was performed at the Hybrid Operating Theater of Mediterraneo Hospital which is a combination of a Cardiac Surgery Operating Theater and a fully equipped Interventional Cardiology Laboratory. Dr. Matthew Panagiotou, Consultant Cardiac Surgeon, Director of Cardiac Surgery Department and Dr. Athanasios Magginas, Consultant Interventional Cardiologist, Director of Cardiology Department and their respective teams made the procedure possible.
After the successful procedure, Mediterraneo Hospital belongs to an international group of hospitals with an increasing experience, being able to offer the full range of surgical and interventional options for the treatment of aortic valve disease.